COMP <GO>
MD vs UNH // ENTERPRISE SCALE & MARKET CAP
Pediatrix Medical Group Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: MD 5
— UNH 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UNH
LAST: $29.18 (+0.93%) • MKT CAP: $2.37B
market-cap
$2.37B
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
market-cap
$368.83B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.57% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 33.60% | 11.47% | +22.13 | MD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.6x | 16.4x | -6.85 | MD | /valuation <GO> |
| Free Cash Flow Yield | 11.43% | 6.48% | +4.95 | MD | /fcf-yield <GO> |
| Operating Margin | — | 4.82% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 3.14% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 6.46% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.7 | 59.2 | +12.47 | MD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 13.3x | 17.1x | -3.79 | MD | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $2.37B | $368.83B | -$366.46B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MD REV | UNH REV | MD GROSS % | UNH GROSS % | MD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $447.57B | — | 88.7% | $271.1M | $16.07B |
| FY 2024 | $0 | $400.28B | — | 88.3% | $206.6M | $20.70B |
| FY 2023 | $0 | $371.62B | — | 89.6% | $137.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MD // BETA —
UNH // BETA 0.33